# DESVENLAFAXINE SUCCINATE
> **ANDA204065** · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL · Approved 2016-07-29
## Drug
- **FDA Application Number:** ANDA204065
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DESVENLAFAXINE SUCCINATE
- **Generic name:** DESVENLAFAXINE
- **Active ingredients:** DESVENLAFAXINE SUCCINATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ACTAVIS LABS FL
- **Manufacturer:** Actavis Pharma, Inc.
- **First approval:** 2016-07-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204065)
---
*MORVS · CC0 1.0*